Is long-term use of Valium (diazepam) indicated for anxiety control in patients with alcohol use disorder?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Long-term Valium (Diazepam) Use for Anxiety Control in Alcoholics

Long-term Valium (diazepam) use is NOT indicated for anxiety control in patients with alcohol use disorder, as the FDA label specifically states that the effectiveness of diazepam in long-term use beyond 4 months has not been assessed by systematic clinical studies. 1

Appropriate Uses of Benzodiazepines in Alcoholism

Benzodiazepines, including diazepam, have clear indications in alcoholism that are limited to:

  1. Acute alcohol withdrawal management:

    • Diazepam is FDA-approved for "symptomatic relief of acute agitation, tremor, impending or acute delirium tremens and hallucinosis" in alcohol withdrawal 1
    • Benzodiazepines are the first-line treatment for alcohol withdrawal syndrome (AWS) 2
  2. Short-term anxiety relief:

    • Diazepam is indicated "for the short-term relief of the symptoms of anxiety" 1
    • The FDA label explicitly states that "anxiety or tension associated with the stress of everyday life usually does not require treatment with an anxiolytic" 1

Risks of Long-term Benzodiazepine Use in Alcoholics

Long-term benzodiazepine use in patients with alcohol use disorder poses significant risks:

  • Addiction potential: Patients with substance use disorders are at high risk of developing dependence on benzodiazepines 3
  • Cross-tolerance: Benzodiazepines and alcohol act on similar GABA pathways, potentially reinforcing addictive patterns
  • Impaired recovery: Long-term benzodiazepine use may interfere with alcohol abstinence goals 4
  • Hepatic concerns: Patients with alcohol-related liver disease may have impaired metabolism of benzodiazepines 2
  • Risk of overdose: Combined use with alcohol significantly increases risk of respiratory depression and death

Preferred Approaches for Anxiety Management in Alcoholics

1. First-line Pharmacotherapy Options:

  • SSRIs: Recommended for persistent anxiety after detoxification 5

    • No abuse potential
    • Safe in patients with alcohol use disorder
    • Effective for various anxiety disorders
  • SNRIs: May be considered as alternative options 5

    • Venlafaxine has shown efficacy in treating anxiety in alcoholics

2. Medications for Maintaining Abstinence:

  • Acamprosate:

    • Safe in liver disease 2
    • Helps maintain abstinence, which often resolves anxiety symptoms
  • Baclofen:

    • Can be used up to 80 mg/day even in patients with liver disease 2
    • May help with both anxiety and alcohol cravings
  • Naltrexone:

    • Helps maintain abstinence motivation
    • May be contraindicated in severe liver disease 2

3. Non-pharmacological Approaches:

  • Cognitive Behavioral Therapy (CBT): Primary approach for treating both alcohol use disorder and anxiety disorders 5
  • Motivational Enhancement Therapy (MET): Effective for addressing underlying alcohol use 5

Special Considerations

  • Liver Disease: For patients with hepatic impairment who require benzodiazepines for withdrawal, short-acting agents like lorazepam or oxazepam are typically recommended over diazepam 2

  • Psychiatric Consultation: Recommended for proper evaluation, treatment planning, and long-term abstinence planning 2

  • Integrated Treatment: Combining substance use disorder treatment with anxiety management is essential for successful outcomes 5

Conclusion

While benzodiazepines like diazepam have a clear role in the acute management of alcohol withdrawal, their long-term use for anxiety control in alcoholics is not supported by evidence and carries significant risks. Alternative pharmacological and non-pharmacological approaches should be prioritized for managing anxiety in patients with alcohol use disorder.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Benzodiazepine treatment for alcohol-dependent patients.

Alcohol and alcoholism (Oxford, Oxfordshire), 1998

Guideline

Management of Anxiety in Alcoholism

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.